FDA Approves Pegulicianine-Based Imaging for Breast Cancer Surgery
The FDA has approved the optical imaging agent pegulicianine (Lumisight) and the LumicellTM Direct Visualization System (DVS)—collectively referred to as LumiSystemTM—for fluorescence-based imaging in adult patients undergoing surgery for breast cancer, …